| 注册
首页|期刊导航|中华医学杂志(英文版)|Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective

Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective

Wen-Jia Shi Wei Zhao

中华医学杂志(英文版)2020,Vol.133Issue(20):2466-2475,10.
中华医学杂志(英文版)2020,Vol.133Issue(20):2466-2475,10.DOI:10.1097/CM9.0000000000001090

Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective

Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective

Wen-Jia Shi 1Wei Zhao2

作者信息

  • 1. Medical School of Chinese People's Liberation Army, Beijing 100039, China
  • 2. Department of Pulmonary and Critical Care Medicine, The General Hospital of People's Liberation Army, Beijing 100853, China
  • 折叠

摘要

关键词

Biomarker/Immune checkpoint inhibitor/Lung cancer

Key words

Biomarker/Immune checkpoint inhibitor/Lung cancer

引用本文复制引用

Wen-Jia Shi,Wei Zhao..Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective[J].中华医学杂志(英文版),2020,133(20):2466-2475,10.

中华医学杂志(英文版)

OACSCDCSTPCDMEDLINESCI

0366-6999

访问量0
|
下载量0
段落导航相关论文